格列美脲产品是Glimepiride is a sulphonylurea derivative that stimulates insulin release from pancreatic beta-cells through inhibition of ATP-sensitive potassium (KATP) channels. Useful to treat patients with type 2 (non-insulin-dependent) diabetes mellitus in whom glycaemia is not controlled by diet and exercise alone.